Transcripts

Ascendis Pharma A/S (ASND) earnings call transcripts

Every Ascendis Pharma A/S earnings call Gloomberb has transcribed, with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed accelerating launches and TransCon platform productivity as supporting long-term growth, while declining to quantify early TransCon CNP trends.

    Aug 13, 2026Confident0.82